Testing a new imaging agent for solid tumors
Part of Cancer, Digestive system, Hormones & metabolism, Kidney & urinary, Lungs & breathing, Women’s health & pregnancy clinical trials.
This study tests a new imaging agent that may help doctors see tumors more clearly using a special scan (SPECT). It is for people with solid tumors to check if the agent is safe and how well it finds cancer cells.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 75 years old and have a solid tumor that is strongly suspected or confirmed by biopsy.
- You should be able to handle daily activities with minimal help (ECOG 0 or 1) and have a life expectancy of at least 6 months.
- You cannot have received radiation therapy in the last 90 days or another experimental drug recently.
- Your liver and kidney function should be within normal limits, and you must not have an active infection.
- You must be able to lie still for 30 minutes during the scan (no claustrophobia or difficulty lying flat).
- You agree to use effective birth control during the study and for 3 months after the test.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new imaging agent that may help doctors see tumors more clearly during a PET scan. It could help diagnose cancer or check if it has returned after treatment.
This trial is testing a new imaging agent called RT01-89Zr to see if it can help detect solid tumors during PET/CT scans. It involves an injection of the agent followed by imaging, and may offer a more targeted way to visualize tumors.
This trial tests a new imaging agent that may help doctors see tumors more clearly during a PET scan. It is for people with certain types of cancer who are willing to have a biopsy of their tumor.
This trial tests a new type of PET scan (a special imaging test) called 89Zr-s-C1 to help detect and monitor solid tumors like melanoma, gastric cancer, or colorectal cancer. The scan may help doctors see tumors more clearly and track whether treatment is working.
This study tests a new PET imaging agent called [68Ga]Ga-ELI411 to help see tumors more clearly. It is for adults with solid tumors who are already scheduled for a standard PET scan, and may help doctors better understand and manage their cancer.
This study tests a new PET scan tracer that aims to highlight cancer cells more clearly. If you join, you'll receive one injection of the tracer and then have a PET/CT scan to help your doctor see whether you have cancer or where it is.
Hear when a new Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.